Research and Markets: Endometrial Cancer Therapeutics Pipeline Review, H1 2015 - 35 Companies 48 Drug Profiles

Business News
Print
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b2g2l4/endometrial) has announced the addition of the "Endometrial Cancer - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Endometrial Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along wit

imageimage
image